NIH-funded research NIH-funded research

Understanding how lung cells develop and recover after injury

Official title: Transcriptional and epigenetic mechanisms of alveologenesis and re-alveologenesis

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11056703 · Data updated 2026-11-12

This study is looking at how lung cells heal and grow back after injuries, like those caused by COVID-19, to help us understand lung diseases better and find new treatments for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2031
Funding year2025
Award (this year)$1,010,116
NIH project number5R35HL171346-02
Project IDNIH-11056703 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include infants and children with chronic lung diseases or those recovering from acute lung injuries.

Less likely to help

Patients with stable lung conditions or those not affected by acute lung injuries may not receive direct benefits from this research.

What this research studies

This research investigates the complex processes of how lung cells, specifically those in the alveoli, develop and regenerate after injury, such as from diseases like COVID-19. By utilizing advanced single-cell technology, the study aims to uncover the transcriptional and epigenetic mechanisms that govern these processes. The research focuses on different cell types involved in lung function and aims to provide insights into conditions like bronchopulmonary dysplasia and acute lung injury. Patients may benefit from a better understanding of lung diseases and potential new treatments derived from this knowledge.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients suffering from severe lung diseases.

How similar studies have gone: Previous research has shown promise in understanding lung cell development and regeneration, indicating that this approach could yield valuable insights.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Chen, Jichao — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Chen, Jichao

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.